Works matching DE "MOLNUPIRAVIR"

Results: 205
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study.

    Published in:
    Current Medical Research & Opinion, 2024, v. 40, n. 8, p. 1323, doi. 10.1080/03007995.2024.2376144
    By:
    • Patel, Vishal;
    • Yarwood, Marcus J.;
    • Levick, Bethany;
    • Gibbons, Daniel C.;
    • Drysdale, Myriam;
    • Kerr, William;
    • Watkins, Jonathan D.;
    • Young, Sophie;
    • Pierce, Benjamin F.;
    • Lloyd, Emily J.;
    • Birch, Helen J.;
    • Kamalati, Tahereh;
    • Brett, Stephen J.
    Publication type:
    Article
    11

    Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45641-0
    By:
    • Standing, Joseph F.;
    • Buggiotti, Laura;
    • Guerra-Assuncao, Jose Afonso;
    • Woodall, Maximillian;
    • Ellis, Samuel;
    • Agyeman, Akosua A.;
    • Miller, Charles;
    • Okechukwu, Mercy;
    • Kirkpatrick, Emily;
    • Jacobs, Amy I.;
    • Williams, Charlotte A.;
    • Roy, Sunando;
    • Martin-Bernal, Luz M.;
    • Williams, Rachel;
    • Smith, Claire M.;
    • Sanderson, Theo;
    • Ashford, Fiona B.;
    • Emmanuel, Beena;
    • Afzal, Zaheer M.;
    • Shields, Adrian
    Publication type:
    Article
    12

    Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40556-8
    By:
    • Cox, Robert M.;
    • Lieber, Carolin M.;
    • Wolf, Josef D.;
    • Karimi, Amirhossein;
    • Lieberman, Nicole A. P.;
    • Sticher, Zachary M.;
    • Roychoudhury, Pavitra;
    • Andrews, Meghan K.;
    • Krueger, Rebecca E.;
    • Natchus, Michael G.;
    • Painter, George R.;
    • Kolykhalov, Alexander A.;
    • Greninger, Alexander L.;
    • Plemper, Richard K.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Molnupiravir and Its Antiviral Activity Against COVID-19.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.855496
    By:
    • Tian, Lili;
    • Pang, Zehan;
    • Li, Maochen;
    • Lou, Fuxing;
    • An, Xiaoping;
    • Zhu, Shaozhou;
    • Song, Lihua;
    • Tong, Yigang;
    • Fan, Huahao;
    • Fan, Junfen
    Publication type:
    Article
    25
    26
    27
    28

    Molnupiravir.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 60, doi. 10.18773/austprescr.2022.014
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk.

    Published in:
    Journal of Infectious Diseases, 2023, v. 228, n. 12, p. 1667, doi. 10.1093/infdis/jiad324
    By:
    • Paraskevis, Dimitrios;
    • Gkova, Maria;
    • Mellou, Kassiani;
    • Gerolymatos, Gerasimos;
    • Psalida, Naya;
    • Gkolfinopoulou, Kassiani;
    • Kostaki, Evangelia-Georgia;
    • Loukides, Stylianos;
    • Kotanidou, Anastasia;
    • Skoutelis, Athanasios;
    • Thiraios, Eleftherios;
    • Saroglou, Georgios;
    • Zografopoulos, Dimitrios;
    • Filippou, Dimitrios;
    • Mossialos, Elias;
    • Zaoutis, Theoklis;
    • Gaga, Mina;
    • Tsiodras, Sotirios;
    • Antoniadou, Anastasia
    Publication type:
    Article
    39
    40

    Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments.

    Published in:
    Journal of Infectious Diseases, 2023, v. 228, n. 5, p. 591, doi. 10.1093/infdis/jiad058
    By:
    • Akazawa, Daisuke;
    • Ohashi, Hirofumi;
    • Hishiki, Takayuki;
    • Morita, Takeshi;
    • Iwanami, Shoya;
    • Kim, Kwang Su;
    • Jeong, Yong Dam;
    • Park, Eun-Sil;
    • Kataoka, Michiyo;
    • Shionoya, Kaho;
    • Mifune, Junki;
    • Tsuchimoto, Kana;
    • Ojima, Shinjiro;
    • Azam, Aa Haeruman;
    • Nakajima, Shogo;
    • Park, Hyeongki;
    • Yoshikawa, Tomoki;
    • Shimojima, Masayuki;
    • Kiga, Kotaro;
    • Iwami, Shingo
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

    Published in:
    Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2715, doi. 10.1007/s10238-022-00949-3
    By:
    • Suzuki, Yasuhito;
    • Shibata, Yoko;
    • Minemura, Hiroyuki;
    • Nikaido, Takefumi;
    • Tanino, Yoshinori;
    • Fukuhara, Atsuro;
    • Kanno, Ryuzo;
    • Saito, Hiroyuki;
    • Suzuki, Shuzo;
    • Inokoshi, Yayoi;
    • Sando, Eiichiro;
    • Sakuma, Hirofumi;
    • Kobayashi, Tatsuho;
    • Kume, Hiroaki;
    • Kamimoto, Masahiro;
    • Aoki, Hideko;
    • Takama, Akira;
    • Iizuka, Taku;
    • Kamiyama, Takamichi;
    • Nakayama, Masaru
    Publication type:
    Article
    47
    48
    49
    50

    Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation.

    Published in:
    Open Forum Infectious Diseases, 2022, v. 9, n. 10, p. 1, doi. 10.1093/ofid/ofac527
    By:
    • Brown, Michael;
    • Saund, Jasjot;
    • Qureshi, Azka;
    • Plowright, Megan;
    • Drury, Katie;
    • Gahir, Joshua;
    • Simpson, Tom;
    • Newman, Thomas;
    • Adams, Kate;
    • Galloway, James;
    • Durairaj, Kezia;
    • Elgizouli, Kamla;
    • Rampling, Tommy;
    • Cole, Joby;
    • Easom, Nicholas;
    • Goodman, Anna L;
    • Marks, Michael
    Publication type:
    Article